On May 1, 2025, Eli Lilly announced that it withdrew its FDA application for Zepbound (tirzepatide) for the treatment of HFpEF in patients with obesity, stating that the FDA requires an additional confirmatory trial to support the application
Cancellation is one button in the portal, no retention phone call, and Eden offers a prorated refund if the provider confirms a medical reason to stop
With Berberine & Panax Ginseng
The result isnt just a tighter chin
Medicaid, however, can cover obesity-related services, including body mass index (BMI) screening, education, nutrition and physical activity, counseling, prescription drugs that promote weight loss, and bariatric surgery as appropriatedepending on the state you live in
Geographic Availability Available in all 50 states (eligibility for compounded meds varies by state) Oral kits restricted in some states Clinical Oversight and Safety Licensed clinicians oversee prescriptions based on form submission
